- Home
- BLZE vs HRTX Comparison
BLZE vs HRTX Comparison
Compare BLZE & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLZE | HRTX |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.8M | 228.3M |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | BLZE | HRTX |
|---|---|---|
| Price | $7.32 | $0.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $7.60 | $4.50 |
| AVG Volume (30 Days) | ★ 2.6M | 2.5M |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $145,835,000.00 | ★ $154,904,000.00 |
| Revenue This Year | $10.16 | $15.28 |
| Revenue Next Year | $10.91 | $20.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 14.27 | 7.36 |
| 52 Week Low | $3.26 | $0.74 |
| 52 Week High | $10.86 | $2.30 |
Technical Indicators
Market Signals| Indicator | BLZE | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 70.56 | 39.06 |
| Support Level | $7.02 | $0.74 |
| Resistance Level | $8.29 | $1.34 |
| Average True Range (ATR) | 0.61 | 0.07 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 71.55 | 8.81 |
Price Performance
Historical ComparisonAbout BLZE Backblaze Inc.
Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.